Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
0.6500
-0.0240 (-3.56%)
At close: Sep 9, 2025, 4:00 PM
0.6500
0.00 (0.00%)
After-hours: Sep 9, 2025, 7:39 PM EDT

Aethlon Medical Stock Forecast

AEMD's stock price has decreased by -76.79% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts that cover Aethlon Medical stock have a consensus rating of "Buy" and an average price target of $28.75, which forecasts a 4,323.08% increase in the stock price over the next year. The lowest target is $1.50 and the highest is $56.

Price Target: $28.75 (+4,323.08%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$1.50$28.75$56$56
Change+130.77%+4323.1%+8515.4%+8515.4%

Analyst Ratings

The average analyst rating for Aethlon Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy111111
Buy000000
Hold000111
Sell000000
Strong Sell000000
Total111222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$1.5
HoldReiterates$1.5+130.77%Aug 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Initiates
$1.5
HoldInitiates$1.5+130.77%Jul 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$56
Strong BuyReiterates$56+8,515.38%Mar 10, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$56
Strong BuyReiterates$56+8,515.38%Feb 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$56
Strong BuyReiterates$56+8,515.38%Jan 30, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.92
from -8.58
EPS Next Year
-0.60
from -1.92
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2021Mar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
659.10K294.17K574.25K----
Revenue Growth
1.37%-55.37%95.21%----
EPS
-52.18-56.47-46.86-38.87-8.58-1.92-0.60
EPS Growth
-------
Forward PE
-------
No. Analysts
-----54
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030
High-0.95-0.60
Avg-1.92-0.60
Low-2.99-0.60

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.